Preoperative Gabapentine for Carpal Tunnel
Primary Purpose
Carpal Tunnel Syndrome
Status
Completed
Phase
Phase 3
Locations
Study Type
Interventional
Intervention
Gabapentine
Sugar pill
Sponsored by
About this trial
This is an interventional treatment trial for Carpal Tunnel Syndrome focused on measuring gabapentine, postoperative pain
Eligibility Criteria
Inclusion Criteria:
- carpal tunnel syndrome
Exclusion Criteria:
- disorientation, psychiatric disease, myocardial ischemia, hypertension, arrhythmia, another pain syndrome, drug user, and pregnant
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
preoperative gabapentine,
sugar pill
Arm Description
Gabapentine
Placebo group
Outcomes
Primary Outcome Measures
Pain Intensity
Numerical score from 0 to 10; zero means no pain and 10 is the more intense pain
Secondary Outcome Measures
Chronic Pain
Numerical score from 0 to 10 scale:
Minimum value= zero (means no pain) and Maximum value= 10 (more intense pain)
Full Information
NCT ID
NCT01632215
First Posted
June 28, 2012
Last Updated
February 12, 2019
Sponsor
Federal University of São Paulo
1. Study Identification
Unique Protocol Identification Number
NCT01632215
Brief Title
Preoperative Gabapentine for Carpal Tunnel
Official Title
Effect of Preoperative Gabapentine for Carpal Tunnel Syndrome
Study Type
Interventional
2. Study Status
Record Verification Date
February 2019
Overall Recruitment Status
Completed
Study Start Date
March 2010 (Actual)
Primary Completion Date
August 2011 (Actual)
Study Completion Date
March 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Federal University of São Paulo
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study was to evaluate the postoperative analgesic effect of preoperative gabapentine for carpal tunnel syndrome surgery.
Detailed Description
There was studied 40 patients. Group 1 patients received 600 mg of gabapentin 1 hour before surgery; G2 received placebo 1 hour before surgery.
Anesthesia was regional intravenous block. Postoperative analgesia when needed was with acetaminophen. If needed was administered codeine. The evaluation of neuropathic pain was made by DN4 questionnaire. Pain intensity was assessed by numeric scale at block and after 30min, 1h, 2h, 2wk, 4wk, 6m. It was noted the duration of analgesia, and the amount of acetaminophen and codeine.
The statistical program used for analysis of the results was the Instat Graph
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Carpal Tunnel Syndrome
Keywords
gabapentine, postoperative pain
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
40 (Actual)
8. Arms, Groups, and Interventions
Arm Title
preoperative gabapentine,
Arm Type
Experimental
Arm Description
Gabapentine
Arm Title
sugar pill
Arm Type
Placebo Comparator
Arm Description
Placebo group
Intervention Type
Drug
Intervention Name(s)
Gabapentine
Other Intervention Name(s)
Anticonvulsant
Intervention Description
Gabapentine 600 mg 01 dose
Intervention Type
Other
Intervention Name(s)
Sugar pill
Intervention Description
Sugar pill 01 dose
Primary Outcome Measure Information:
Title
Pain Intensity
Description
Numerical score from 0 to 10; zero means no pain and 10 is the more intense pain
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Chronic Pain
Description
Numerical score from 0 to 10 scale:
Minimum value= zero (means no pain) and Maximum value= 10 (more intense pain)
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
carpal tunnel syndrome
Exclusion Criteria:
disorientation, psychiatric disease, myocardial ischemia, hypertension, arrhythmia, another pain syndrome, drug user, and pregnant
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rioko K Sakata, PhD
Organizational Affiliation
Universidade Federal de São Paulo
Official's Role
Study Director
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Preoperative Gabapentine for Carpal Tunnel
We'll reach out to this number within 24 hrs